ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS)

CAPS Rating: 3 out of 5

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.

Recs

1
Player Avatar rofgile (99.33) Submitted: 12/10/2010 12:25:25 AM : Underperform Start Price: $9.50 ISIS Score: -207.86

RNAi, please die.

Featured Broker Partners


Advertisement